Loteprednol Etabonate Patent Expiration
Loteprednol Etabonate is Used for treating steroid-responsive conditions in the eye, such as inflammation of the conjunctiva, cornea, and anterior segment. It was first introduced by Bausch And Lomb Inc
Loteprednol Etabonate Patents
Given below is the list of patents protecting Loteprednol Etabonate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lotemax Sm | US10596107 | Ophthalmic suspension composition | Dec 23, 2036 | Bausch And Lomb Inc |
| Lotemax Sm | US11534395 | Ophthalmic suspension composition | Jan 26, 2036 | Bausch And Lomb Inc |
| Eysuvis | US10058511 | Nanocrystals, compositions, and methods that aid particle transport in mucus | May 03, 2033 | Alcon Labs Inc |
| Eysuvis | US10646436 | Compositions and methods for ophthalmic and/or other applications | May 03, 2033 | Alcon Labs Inc |
| Eysuvis | US10688045 | Compositions and methods for ophthalmic and/or other applications | May 03, 2033 | Alcon Labs Inc |
| Eysuvis | US10857096 | Compositions and methods for ophthalmic and/or other applications | May 03, 2033 | Alcon Labs Inc |
| Eysuvis | US10940108 | Compositions and methods for ophthalmic and/or other applications | May 03, 2033 | Alcon Labs Inc |
| Eysuvis | US10945948 | Compositions and methods for ophthalmic and/or other applications | May 03, 2033 | Alcon Labs Inc |
| Eysuvis | US10993908 | Compositions and methods for ophthalmic and/or other applications | May 03, 2033 | Alcon Labs Inc |
| Eysuvis | US11219596 | Compositions and methods for ophthalmic and/or other applications | May 03, 2033 | Alcon Labs Inc |
| Eysuvis | US11596599 | Compositions and methods for ophthalmic and/or other applications | May 03, 2033 | Alcon Labs Inc |
| Eysuvis | US11642317 | Nanocrystals, compositions, and methods that aid particle transport in mucus | May 03, 2033 | Alcon Labs Inc |
| Eysuvis | US11872318 | Nanocrystals, compositions, and methods that aid particle transport in mucus | May 03, 2033 | Alcon Labs Inc |
| Eysuvis | US12115246 | Compositions and methods for ophthalmic and/or other applications | May 03, 2033 | Alcon Labs Inc |
| Eysuvis | US9056057 | Nanocrystals, compositions, and methods that aid particle transport in mucus | May 03, 2033 | Alcon Labs Inc |
| Eysuvis | US9393213 | Nanocrystals, compositions, and methods that aid particle transport in mucus | May 03, 2033 | Alcon Labs Inc |
| Eysuvis | US9532955 | Nanocrystals, compositions, and methods that aid particle transport in mucus | May 03, 2033 | Alcon Labs Inc |
| Eysuvis | US9737491 | Nanocrystals, compositions, and methods that aid particle transport in mucus | May 03, 2033 | Alcon Labs Inc |
| Eysuvis | US9827191 | Compositions and methods for ophthalmic and/or other applications | May 03, 2033 | Alcon Labs Inc |
| Inveltys | US10058511 | Nanocrystals, compositions, and methods that aid particle transport in mucus | May 03, 2033 | Alcon Labs Inc |
| Inveltys | US10646437 | Compositions and methods for ophthalmic and/or other applications | May 03, 2033 | Alcon Labs Inc |
| Inveltys | US10688045 | Compositions and methods for ophthalmic and/or other applications | May 03, 2033 | Alcon Labs Inc |
| Inveltys | US10864219 | Compositions and methods for ophthalmic and/or other applications | May 03, 2033 | Alcon Labs Inc |
| Inveltys | US11219597 | Compositions and methods for ophthalmic and/or other applications | May 03, 2033 | Alcon Labs Inc |
| Inveltys | US11642317 | Nanocrystals, compositions, and methods that aid particle transport in mucus | May 03, 2033 | Alcon Labs Inc |
| Inveltys | US11872318 | Nanocrystals, compositions, and methods that aid particle transport in mucus | May 03, 2033 | Alcon Labs Inc |
| Inveltys | US12115246 | Compositions and methods for ophthalmic and/or other applications | May 03, 2033 | Alcon Labs Inc |
| Inveltys | US9056057 | Nanocrystals, compositions, and methods that aid particle transport in mucus | May 03, 2033 | Alcon Labs Inc |
| Inveltys | US9393213 | Nanocrystals, compositions, and methods that aid particle transport in mucus | May 03, 2033 | Alcon Labs Inc |
| Inveltys | US9532955 | Nanocrystals, compositions, and methods that aid particle transport in mucus | May 03, 2033 | Alcon Labs Inc |
| Inveltys | US9737491 | Nanocrystals, compositions, and methods that aid particle transport in mucus | May 03, 2033 | Alcon Labs Inc |
| Inveltys | US9827191 | Compositions and methods for ophthalmic and/or other applications | May 03, 2033 | Alcon Labs Inc |
| Lotemax | US5800807 | Ophthalmic compositions including glycerin and propylene glycol |
Jan 29, 2017
(Expired) | Bausch And Lomb Inc |
| Alrex |
US5540930 (Pediatric) | Suspension of loteprednol etabonate for ear, eye, or nose treatment |
Apr 25, 2014
(Expired) | Bausch And Lomb |
| Alrex |
US5747061 (Pediatric) | Suspension of loteprednol etabonate for ear, eye, or nose treatment |
Apr 25, 2014
(Expired) | Bausch And Lomb |
| Lotemax |
US5540930 (Pediatric) | Suspension of loteprednol etabonate for ear, eye, or nose treatment |
Apr 25, 2014
(Expired) | Bausch And Lomb |
| Lotemax |
US5747061 (Pediatric) | Suspension of loteprednol etabonate for ear, eye, or nose treatment |
Apr 25, 2014
(Expired) | Bausch And Lomb |
| Alrex | US5540930 | Suspension of loteprednol etabonate for ear, eye, or nose treatment |
Oct 25, 2013
(Expired) | Bausch And Lomb |
| Alrex | US5747061 | Suspension of loteprednol etabonate for ear, eye, or nose treatment |
Oct 25, 2013
(Expired) | Bausch And Lomb |
| Lotemax | US5540930 | Suspension of loteprednol etabonate for ear, eye, or nose treatment |
Oct 25, 2013
(Expired) | Bausch And Lomb |
| Lotemax | US5540930 | Suspension of loteprednol etabonate for ear, eye, or nose treatment |
Oct 25, 2013
(Expired) | Pharmos |
| Lotemax | US5747061 | Suspension of loteprednol etabonate for ear, eye, or nose treatment |
Oct 25, 2013
(Expired) | Bausch And Lomb |
| Alrex |
US4996335 (Pediatric) | Soft steroids having anti-inflammatory activity |
Sep 09, 2012
(Expired) | Bausch And Lomb |
| Lotemax |
US4996335 (Pediatric) | Soft steroids having anti-inflammatory activity |
Sep 09, 2012
(Expired) | Bausch And Lomb |
Loteprednol Etabonate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List